Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
'People Could Go To Jail': OAN Reports WH Leakers Identified, Trump Set To Fire Three Staffers
CNN: Manchester Bombing May Be 'Right-Wing False Flag'
Full Transcript Of Trump's Call With Philippines President Rodrigo Duterte Leaks
Richard Spencer Has Gym Membership Revoked After Getting Yelled At By SJW Professor
New Democrat FOX News Host Attacks 'Seth Rich Conspiracy Theorists'
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.